Endothelin B Receptor Antagonists

DBCAT001699Pharmacologic class

Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN B RECEPTORS. A DrugBank category of 3 drugs. 1 of them is approved.

Also known as: Antagonists, Endothelin B Receptor · Blockers, Endothelin B Receptor · Endothelin B Receptor Blockers
Drugs: Actelion-1
BQ-788
Macitentan

What you can answer from here — as of August 24, 2016

3DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

70Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Endothelin B Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account